Skip to content
10-K

Annual Report

Foamix Pharmaceuticals Ltd.

0001178913-20-000792

← back to feed
Filed
Mar 12, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Mar 1, 2020 61.63M sh
Capex FY 2019 · Dec 31, 2019 $1.06M
Capex FY 2019 · Dec 31, 2018 $567K
Capex FY 2019 · Dec 31, 2017 $1.52M
Operating Cash Flow FY 2019 · Dec 31, 2019 −$73.39M
Operating Cash Flow FY 2019 · Dec 31, 2018 −$68.66M
Operating Cash Flow FY 2019 · Dec 31, 2017 −$53.18M
Long Term Debt FY 2019 · Dec 31, 2019 $32.73M
Cash And Equivalents FY 2019 · Dec 31, 2019 $43.76M
Cash And Equivalents FY 2019 · Dec 31, 2018 $27.87M
Cash And Equivalents FY 2019 · Dec 31, 2017 $15.96M
Stockholders Equity FY 2019 · Dec 31, 2019 $17.58M
Stockholders Equity FY 2019 · Dec 31, 2018 $92.18M
Stockholders Equity FY 2019 · Dec 31, 2017 $68.6M
Stockholders Equity FY 2019 · Dec 31, 2016 $129.99M
Current Liabilities FY 2019 · Dec 31, 2019 $29.33M
Current Liabilities FY 2019 · Dec 31, 2018 $10.47M
Total Liabilities FY 2019 · Dec 31, 2019 $63.58M
Total Liabilities FY 2019 · Dec 31, 2018 $11.55M
Current Assets FY 2019 · Dec 31, 2019 $76.41M
Current Assets FY 2019 · Dec 31, 2018 $101.17M
Total Assets FY 2019 · Dec 31, 2019 $81.16M
Total Assets FY 2019 · Dec 31, 2018 $103.73M
Sga Expense FY 2019 · Dec 31, 2019 $45.11M
Sga Expense FY 2019 · Dec 31, 2018 $14.01M
Sga Expense FY 2019 · Dec 31, 2017 $11.49M
Rd Expense FY 2019 · Dec 31, 2019 $51.2M
Rd Expense FY 2019 · Dec 31, 2018 $64.47M
Rd Expense FY 2019 · Dec 31, 2017 $57.78M
Net Income FY 2019 · Dec 31, 2019 −$95.18M
Net Income FY 2019 · Dec 31, 2018 −$74.16M
Net Income FY 2019 · Dec 31, 2017 −$65.72M
Operating Income FY 2019 · Dec 31, 2019 −$37.43M
Operating Income FY 2019 · Dec 31, 2019 −$95.87M
Operating Income FY 2019 · Sep 30, 2019 −$23.2M
Operating Income FY 2019 · Jun 30, 2019 −$19.36M
Operating Income FY 2019 · Mar 31, 2019 −$15.88M
Operating Income restated FY 2019 · Dec 31, 2018 −$14.8M
Operating Income FY 2019 · Dec 31, 2018 −$74.89M
Operating Income restated FY 2019 · Sep 30, 2018 −$15.59M
Operating Income restated FY 2019 · Jun 30, 2018 −$18.79M
Operating Income restated FY 2019 · Mar 31, 2018 −$25.72M
Operating Income FY 2019 · Dec 31, 2017 −$65.61M
Gross Profit FY 2019 · Dec 31, 2019 $135K
Gross Profit FY 2019 · Dec 31, 2019 $443K
Gross Profit FY 2019 · Mar 31, 2019 $308K
Gross Profit FY 2019 · Dec 31, 2018 $860K
Gross Profit FY 2019 · Dec 31, 2018 $3.6M
Gross Profit FY 2019 · Sep 30, 2018 $865K
Gross Profit FY 2019 · Jun 30, 2018 $964K
Gross Profit FY 2019 · Mar 31, 2018 $906K
Gross Profit FY 2019 · Dec 31, 2017 $3.66M
Revenue FY 2019 · Dec 31, 2019 $135K
Revenue FY 2019 · Dec 31, 2019 $443K
Revenue FY 2019 · Mar 31, 2019 $308K
Revenue FY 2019 · Dec 31, 2018 $860K
Revenue FY 2019 · Dec 31, 2018 $3.6M
Revenue FY 2019 · Sep 30, 2018 $865K
Revenue FY 2019 · Jun 30, 2018 $964K
Revenue FY 2019 · Mar 31, 2018 $906K
Revenue FY 2019 · Dec 31, 2017 $3.67M
Cost Of Revenue FY 2019 · Dec 31, 2017 $13K